Apollo Cancer Centres Introduces South Asia’s First & Most Advanced Robotic Radiosurgery System

Bhubaneswar: Ushering in another new era in healthcare, Apollo Cancer Centre, Chennai has introduced South Asia’s first CyberKnifeCyberKnife® S7™ FIM Robotic Radio Surgery System- offering a revolutionary treatment modality of cancerous and non-cancerous tumors. The introduction of the CyberKnife System marks a transformative moment for cancer care and technology, and Apollo Cancer Centre has set a new standard by being the first in South Asia to introduce this ground-breaking technology. The CyberKnife® S7™ FIM System is a non-invasive treatment for cancerous and non-cancerous tumors and other conditions where radiation therapy is indicated. It is used to treat conditions throughout the body including brain, lung, spine, prostate and abdominal cancers, and may be an alternative to surgery for patients who have inoperable or surgically complex tumors. Even patients previously treated with radiation, who have metastatic lesions or with recurrent cancers can receive CyberKnife treatment. Dr Mahadev Potharaju, Senior Consultant – Radiation Oncology, elaborated “CyberKnife® S7™ FIM treatments are typically performed in 1 to 5 sessions. The treatment duration typically ranges from 30 to 90 minutes, during which 100 to 200 radiation beams are administered from various angles. Each beam lasts for approximately 10 to 15 seconds. Treatment sessions are non-invasive outpatient procedures, and no anaesthesia or incisions are required, enabling most patients to continue with daily activities over the course of treatment.” The CyberKnife System is the only radiation delivery system that features a radiation delivery device, called a linear accelerator, directly mounted on a robot to deliver the highenergy X-rays or photons used in radiation therapy. It uses real-time image guidance and a robot to deliver doses from thousands of beam angles and setting a new standard for delivery precision anywhere in the body. Apollo Cancer Centre has an expert team of specialists who have been adept at using Cyberknife technology for the past 15 years. So far, ACC has seen 3,000 cases from across India and abroad. The extremely advanced cutting-edge technology has come a long way since then. Today, the hospital has once again set a new benchmark as the first in South Asia to launch the next generation CyberKnife® S7™ FIM system, revolutionizing the approach to cancer treatment. Apollo Cancer Centre is also the first in the country to be accredited for offering a Certified fellowship training program in CyberKnife®, emphasizing the group’s commitment towards training and medical education.

About Post Author